Regenerative Medicine Market worth USD 64919.7 Million by 2025 | CAGR of 33.05% - Progressive Markets

Progressive Markets published a report, titled, Regenerative Medicine Market: Size, Trend, Share, Opportunity Analysis & Forecast, 2016-2025, which projects that the market was valued at $6677.7 million in 2017, and is expected to reach $64919.7 million by 2025, registering a CAGR of 33.05% during the period, 2018-2025.


Pune, Aug. 07, 2018 (GLOBE NEWSWIRE) -- The report offers a comprehensive analysis of the "global regenerative medicine market", including the market size, share, segmentation, forecast, drivers, restraints & opportunities; and key market players along with their profiles. The report aims at catering to various stakeholders, including market players, investors, industry leaders, and others, who wish to understand the latest trends, current market scenario, and latest technologies used in the industry. In addition, the study would assist them to understand the top 10 players along with the growth strategies adopted by them for better industry benchmarking.

Request Sample Report:

The report provides information about the factors that drive or hamper the adoption of regenerative medicine market. The market is driven by the rapid progress in technology for the regeneration of organs and tissues, the growing occurrence of chronic diseases all over the world, the increase in the government and private funding for the development of regenerative diseases, and the growth in geriatric population are causing the industry to grow fast. On the other hand, the high cost of regenerative medicines and stringent government regulations impede the growth of the regenerative medicine market.

The report analyzes the global regenerative medicine market based on type, material, application, and geography. Based on type, the market is classified into tissue engineering, cell therapy, small molecules & biologics, and gene therapy. The cell therapy segment is likely to grow at a CAGR of 32.74% during the forecast period. The tissue engineering segment is expected to garner $6825.4 million by 2025. Based on material, the market is classified into synthetic materials, biologically derived materials, genetically engineered materials, and small molecules and biologics. The synthetic materials segment is expected to garner $22304.8 million by 2025. Based on application, the market is divided into cardiovascular, oncology, dermatology, musculoskeletal, wound healing, ophthalmology, neurology, and others. The cardiovascular sector is likely to grow at a CAGR of 37.61% and the musculoskeletal segment is likely to grow at a CAGR of 32.44% during the forecast period. Based on geography, the market is divided into North America, Europe, Asia-Pacific, and LAMEA. In North America, the study is analyzed across the US, Canada, and Mexico. In Europe, the study covers Germany, France, UK, Spain, Russia, and the rest of Europe. In Asia-Pacific, the study covers Japan, China, Australia, India, South Korea, Taiwan, and the rest of APAC. In LAMEA, the study covers Brazil, Turkey, Venezuela, Saudi Arabia, Republic of South Africa, and the rest of LAMEA.

Get 20% Discount On Customization:

The report includes the profiles of leading players in the regenerative medicine market, including Zimmer Biomet Holdings, Inc., Medtronic plc, Stryker Corporation, Ocata Therapeutics, Inc., Baxter International, Inc., DePuy Synthes, Organogenesis, Inc., Integra Lifesciences Holdings Corporation, Acelity Holdings, Inc., and CryoLife, Inc. The report includes detailed information about the impact of factors, including driver, restraints, and opportunities on the growth of the market.